Structures by: Hützler W. M.
Total: 53
(S)-2-methyl-3,4,5,6-tetrahydropyrimidine-4-carboxylic acid
C6H10N2O2
CrystEngComm (2020) 22, 2 169-172
a=5.21733(4)Å b=9.11328(7)Å c=14.35413(11)Å
α=90° β=90.7911(3)° γ=90°
(S)-2-methyl-3,4,5,6-tetrahydropyrimidine-4-carboxylic acid
C6H10N2O2,2(H2O)
CrystEngComm (2020) 22, 2 169-172
a=7.5940(3)Å b=8.6265(5)Å c=13.3619(6)Å
α=90° β=90° γ=90°
Ectoine
C6H10N2O2,2(H2O)
CrystEngComm (2020) 22, 2 169-172
a=7.5940(3)Å b=8.6265(5)Å c=13.3619(6)Å
α=90° β=90° γ=90°
Pigment Red 48 monosodium salt dihydrate
Na,C18H12ClN2O6S,2(H2O)
Acta Crystallographica Section C Structural Chemistry (2020) 76, 8
a=18.5318(9)Å b=5.9396(3)Å c=17.4426(10)Å
α=90° β=95.528(4)° γ=90°
Pigment Red 48 monosodium salt monohydrate
Na,C18H12ClN2O6S,H2O
Acta Crystallographica Section C Structural Chemistry (2020) 76, 8
a=18.2222(2)Å b=5.94860(10)Å c=16.9361(2)Å
α=90° β=92.0370(10)° γ=90°
5-Methyl-2-thiouracil--2,4-diamino-6-phenyl-1,3,5-triazine--<i>N</i>,<i>N</i>-dimethylformamide (2/2/1)
C9H9N5,C5H6N2OS,0.5(C3H7NO)
Acta Crystallographica Section C (2018) 74, 1 21-30
a=11.1237(13)Å b=19.5259(14)Å c=16.7313(16)Å
α=90° β=100.900(8)° γ=90°
5-Methyl-2-thiouracil--2,4-diaminopyrimidine (1/2)
C5H6N2OS,2(C4H6N4)
Acta Crystallographica Section C (2018) 74, 1 21-30
a=7.7255(9)Å b=9.1381(14)Å c=12.4594(17)Å
α=92.241(11)° β=104.034(10)° γ=97.248(11)°
5-Methyl-2-thiouracil--2,4-diaminopyrimidine--<i>N</i>,<i>N</i>-dimethylformamide (2/2/1)
2(C5H6N2OS),C3H7NO,2(C4H6N4)
Acta Crystallographica Section C (2018) 74, 1 21-30
a=10.0743(10)Å b=14.3830(10)Å c=18.647(2)Å
α=90° β=100.427(8)° γ=90°
5-Methyl-2-thiouracil--6-amino-3<i>H</i>-isocytosine--<i>N</i>,<i>N</i>-dimethylformamide (2/2/1)
2(C5H6N2OS),2(C4H6N4O),C3H7NO
Acta Crystallographica Section C (2018) 74, 1 21-30
a=22.573(3)Å b=9.1593(12)Å c=13.9211(16)Å
α=90° β=98.701(10)° γ=90°
5-Methyl-2-thiouracil--6-amino-3<i>H</i>-isocytosine--<i>N</i>,<i>N</i>-dimethylacetamide (2/2/1)
2(C5H6N2OS),2(C4H6N4O),C4H9NO
Acta Crystallographica Section C (2018) 74, 1 21-30
a=23.530(3)Å b=8.7478(9)Å c=14.2006(16)Å
α=90° β=102.037(10)° γ=90°
5-Methyl-2-thiouracil--melamine (3/2)
3(C5H6N2OS),2(C3H6N6)
Acta Crystallographica Section C (2018) 74, 1 21-30
a=17.6827(7)Å b=17.6827(7)Å c=16.4925(9)Å
α=90° β=90° γ=120°
Pyrimidine-2,4-diamine
C4H6N4
Acta Crystallographica Section C (2016) 72, 9
a=12.0330(17)Å b=4.0256(3)Å c=11.5992(15)Å
α=90° β=118.346(10)° γ=90°
Pyrimidine-2,4-diamine--1,4-dioxane (2/1)
C4H6N4,0.5(C4H8O2)
Acta Crystallographica Section C (2016) 72, 9
a=7.6282(14)Å b=7.2157(9)Å c=13.879(2)Å
α=90° β=102.243(15)° γ=90°
Pyrimidine-2,4-diamine--<i>N</i>,<i>N</i>-dimethylacetamide (1/1)
C4H6N4,C4H9NO
Acta Crystallographica Section C (2016) 72, 9
a=8.0055(10)Å b=8.0256(10)Å c=9.3143(11)Å
α=81.779(2)° β=78.053(2)° γ=62.518(2)°
2,4-Diaminopyrimidinium barbiturate
C4H7N4,C4H3N2O3
Acta Crystallographica Section C (2016) 72, 9
a=4.6822(7)Å b=15.948(3)Å c=13.514(2)Å
α=90° β=90.240(13)° γ=90°
Pyrimidine-2,4-diamine--1-methylpyrrolidin-2-one (1/1)
C4H6N4,C5H9NO
Acta Crystallographica Section C (2016) 72, 9
a=7.3870(6)Å b=24.8978(13)Å c=11.5485(8)Å
α=90° β=98.824(6)° γ=90°
2,4-Diaminopyrimidinium 2-thiobarbiturate--<i>N</i>,<i>N</i>-dimethylformamide (1/2)
C4H7N4,C4H3N2O2S,2(C3H7NO)
Acta Crystallographica Section C (2016) 72, 9
a=8.0115(9)Å b=19.2213(14)Å c=12.9531(13)Å
α=90° β=90.230(8)° γ=90°
2,4-Diaminopyrimidinium 2-thiobarbiturate--<i>N</i>,<i>N</i>-dimethylacetamide (1/2)
C4H7N4,C4H3N2O2S,2(C4H9NO)
Acta Crystallographica Section C (2016) 72, 9
a=9.8868(12)Å b=17.2380(14)Å c=12.8571(14)Å
α=90° β=88.151(9)° γ=90°
2,4-Diaminopyrimidinium 6-propyl-2-thiouracilate--2,4-diaminopyrimidine--<i>N</i>,<i>N</i>-dimethylacetamide--water (1/1/1/1)
C4H7N4,C7H9N2OS,C4H6N4,C4H9NO,H2O
Acta Crystallographica Section C (2016) 72, 8
a=7.9688(10)Å b=11.2412(15)Å c=14.6144(19)Å
α=109.442(10)° β=92.075(11)° γ=100.877(11)°
6-Methoxymethyl-2-thiouracil--<i>N</i>,<i>N</i>-dimethylformamide (1/1)
C6H8N2O2S,C3H7NO
Acta Crystallographica Section C (2016) 72, 8
a=7.2516(16)Å b=8.9841(17)Å c=10.736(2)Å
α=109.275(16)° β=109.132(17)° γ=97.283(17)°
6-Methoxymethyl-2-thiouracil--<i>N</i>,<i>N</i>-dimethylacetamide (1/1)
C6H8N2O2S,C4H9NO
Acta Crystallographica Section C (2016) 72, 8
a=8.2090(15)Å b=9.1804(17)Å c=9.5617(17)Å
α=65.128(14)° β=83.198(15)° γ=78.854(14)°
6-Methoxymethyl-2-thiouracil--dimethyl sulfoxide (1/1)
C6H8N2O2S,C2H6OS
Acta Crystallographica Section C (2016) 72, 8
a=8.1891(7)Å b=17.7131(13)Å c=8.3032(8)Å
α=90° β=94.643(8)° γ=90°
6-Methoxymethyl-2-thiouracil--1-methylpyrrolidin-2-one (1/1)
C6H8N2O2S,C5H9NO
Acta Crystallographica Section C (2016) 72, 8
a=6.7673(13)Å b=9.9189(15)Å c=10.4097(17)Å
α=82.868(13)° β=74.093(13)° γ=74.741(13)°
2,4-Diaminopyrimidinium 6-methoxymethyl-2-thiouracilate
C4H7N4,C6H7N2O2S
Acta Crystallographica Section C (2016) 72, 8
a=4.6843(4)Å b=13.9818(19)Å c=19.5128(19)Å
α=90° β=91.450(8)° γ=90°
2,4,6-Triaminopyrimidinium 6-methoxymethyl-2-thiouracilate--6-methoxymethyl-2-thiouracil (1/1)
C4H8N5,C6H7N2O2S,C6H8N2O2S
Acta Crystallographica Section C (2016) 72, 8
a=6.8086(4)Å b=8.1414(5)Å c=18.6651(14)Å
α=90° β=90° γ=90°
5-(Hydroxymethyl)uracil
C5H6N2O3
Acta Crystallographica Section C (2016) 72, 5 379-388
a=4.874(3)Å b=7.663(2)Å c=8.325(3)Å
α=66.97(2)° β=88.09(2)° γ=87.07(2)°
5-Carboxyuracil <i>N</i>,<i>N</i>-dimethylformamide monosolvate
C5H4N2O4,C3H7NO
Acta Crystallographica Section C (2016) 72, 5 379-388
a=8.671(3)Å b=12.394(2)Å c=9.381(2)Å
α=90° β=90.17(2)° γ=90°
5-Carboxyuracil dimethyl sulfoxide monosolvate
C5H4N2O4,C2H6OS
Acta Crystallographica Section C (2016) 72, 5 379-388
a=6.9341(9)Å b=6.9015(5)Å c=20.919(3)Å
α=90° β=96.604(10)° γ=90°
5-Carboxyuracil <i>N</i>,<i>N</i>-dimethylacetamide monosolvate
C5H4N2O4,C4H9NO
Acta Crystallographica Section C (2016) 72, 5 379-388
a=11.7707(19)Å b=6.1053(10)Å c=15.271(3)Å
α=90° β=90.858(13)° γ=90°
4-Oxo-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid dimethylformamide monosolvate
C5H4N2O3S,C3H7NO
Acta Crystallographica Section C (2016) 72, 5 379-388
a=10.1742(10)Å b=11.4616(12)Å c=9.9715(11)Å
α=90° β=104.318(8)° γ=90°
4-Oxo-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid 1,4-dioxane sesquisolvate
C5H4N2O3S,1.5(C4H8O2)
Acta Crystallographica Section C (2016) 72, 5 379-388
a=5.2819(7)Å b=10.3542(12)Å c=13.0071(15)Å
α=89.377(10)° β=85.143(10)° γ=77.700(10)°
4-Oxo-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid
C5H4N2O3S
Acta Crystallographica Section C (2016) 72, 5 379-388
a=11.409(3)Å b=15.552(3)Å c=7.369(2)Å
α=90° β=97.599(19)° γ=90°
6-Methyl-2-thiouracil--2,4-diaminopyrimidine--1-methylpyrrolidin-2-one (1/1/2)
C5H6N2OS,C4H6N4,2(C5H9NO)
Acta Crystallographica Section C (2015) 71, 3
a=13.9475(5)Å b=8.1618(3)Å c=40.9157(14)Å
α=90° β=98.148(3)° γ=90°
6-Methyl-2-thiouracil--2,4-diaminopyrimidine--dimethylformamide (2/1/2)
C5H6N2OS,0.5(C4H6N4),C3H7NO
Acta Crystallographica Section C (2015) 71, 3
a=14.9786(15)Å b=8.2010(11)Å c=22.568(2)Å
α=90° β=99.899(8)° γ=90°
6-Methyl-2-thiouracil--2,4-diaminopyrimidine--dimethylacetamide (2/1/2)
2(C5H6N2OS),C4H6N4,2(C4H9NO)
Acta Crystallographica Section C (2015) 71, 3
a=8.2095(7)Å b=12.8069(11)Å c=14.3391(13)Å
α=89.914(7)° β=76.230(7)° γ=83.418(7)°
6-Methyl-2-thiouracil--6-amino-3<i>H</i>-isocytosine--dimethylformamide (1/1/1)
C5H6N2OS,C4H6N4O,C3H7NO
Acta Crystallographica Section C (2015) 71, 3
a=7.3559(6)Å b=30.068(2)Å c=8.1263(7)Å
α=90° β=115.534(6)° γ=90°
6-Methyl-2-thiouracil--6-amino-3<i>H</i>-isocytosine--dimethyl sulfoxide (1/1/1)
C5H6N2OS,C4H6N4O,C2H6OS
Acta Crystallographica Section C (2015) 71, 3
a=8.2520(7)Å b=23.9532(19)Å c=8.2133(6)Å
α=90° β=102.496(6)° γ=90°
6-Amino-2-thiouracil dimethylformamide disolvate
C4H5N3OS,2(C3H7NO)
Acta Crystallographica Section C (2013) 69, 1 93-100
a=8.0894(16)Å b=12.037(3)Å c=15.390(3)Å
α=89.774(19)° β=89.466(17)° γ=76.691(17)°
6-Amino-2-thiouracil dimethylacetamide monosolvate
C4H5N3OS,C4H9NO
Acta Crystallographica Section C (2013) 69, 1 93-100
a=9.4615(9)Å b=9.2679(11)Å c=13.4208(12)Å
α=90.00° β=101.801(7)° γ=90.00°
6-Amino-2-thiouracil dimethylacetamide sesquisolvate
2(C4H5N3OS),3(C4H9NO)
Acta Crystallographica Section C (2013) 69, 1 93-100
a=15.2133(7)Å b=7.4335(13)Å c=24.445(3)Å
α=90.00° β=90.00° γ=90.00°
6-Amino-2-thiouracil 1-methylpyrrolidin-2-one sesquisolvate
2(C4H5N3OS),3(C5H9NO)
Acta Crystallographica Section C (2013) 69, 1 93-100
a=15.2293(10)Å b=7.5483(4)Å c=25.1871(13)Å
α=90.00° β=90.00° γ=90.00°
6-Amino-2-thiouracil 1-methylpyrrolidin-2-one sesquisolvate
2(C4H5N3OS),3(C5H9NO)
Acta Crystallographica Section C (2013) 69, 1 93-100
a=7.5509(7)Å b=15.2328(12)Å c=50.601(3)Å
α=90.00° β=90.00° γ=90.00°
5,6-Dimethyl-2-thiouracil--dimethyl sulfoxide (2/1)
2(C6H8N2OS),C2H6OS
Acta Crystallographica Section C (2014) 70, 2 241-249
a=8.1597(14)Å b=22.612(3)Å c=10.5576(17)Å
α=90.00° β=105.459(13)° γ=90.00°
5-Methoxy-2-thiouracil
C5H6N2O2S
Acta Crystallographica Section C (2014) 70, 2 241-249
a=4.3141(6)Å b=16.9101(18)Å c=8.9965(12)Å
α=90.00° β=93.593(10)° γ=90.00°
5-Methoxy-2-thiouracil--dimethylacetamide (1/1)
C5H6N2O2S,C4H9NO
Acta Crystallographica Section C (2014) 70, 2 241-249
a=13.225(3)Å b=6.4726(8)Å c=13.867(3)Å
α=90.00° β=97.170(15)° γ=90.00°
5,6-Dimethyl-2-thiouracil
C6H8N2OS
Acta Crystallographica Section C (2014) 70, 2 241-249
a=6.8295(10)Å b=15.2624(18)Å c=7.0948(11)Å
α=90.00° β=112.336(11)° γ=90.00°
5,6-Dimethyl-2-thiouracil--1-methylpyrrolidin-2-one (1/1)
C6H8N2OS,C5H9NO
Acta Crystallographica Section C (2014) 70, 2 241-249
a=15.2437(6)Å b=6.8275(17)Å c=23.555(2)Å
α=90.00° β=90.00° γ=90.00°
5,6-Dimethyl-2-thiouracil--dimethylformamide (2/1)
2(C6H8N2OS),(C3H7NO)
Acta Crystallographica Section C (2014) 70, 2 241-249
a=8.5895(13)Å b=8.6241(14)Å c=15.350(2)Å
α=100.404(13)° β=95.341(12)° γ=119.496(11)°
5,6-Dimethyl2-thiouracil--dimethylacetamide (2/1)
2(C6H8N2OS),C4H9NO
Acta Crystallographica Section C (2014) 70, 2 241-249
a=8.0876(14)Å b=11.1034(17)Å c=11.9115(17)Å
α=80.017(12)° β=70.979(12)° γ=75.575(13)°
4-Oxo-2-sulfanylidene-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid dimethyl sulfoxide monosolvate
C5H4N2O3S,C2H6OS
Acta Crystallographica Section C (2016) 72, 5 379-388
a=7.0475(9)Å b=8.9534(12)Å c=9.2802(13)Å
α=115.790(10)° β=95.753(11)° γ=95.791(10)°
6-Methyl-2-thiouracil--2,4-diaminopyrimidine (1/1)
C5H6N2OS,C4H6N4
Acta Crystallographica Section C (2015) 71, 3
a=6.9996(8)Å b=19.223(2)Å c=17.143(2)Å
α=90° β=90° γ=90°
2,4,6-Triaminopyrimidinium 6-methyl-2-thiouracilate--6-methyl-2-thiouracil--dimethylformamide (1/1/1)
C4H8N5,C5H5N2OS,C5H6N2OS,2(C3H7NO)
Acta Crystallographica Section C (2015) 71, 3
a=8.2680(8)Å b=6.6000(4)Å c=25.043(2)Å
α=90° β=98.887(7)° γ=90°
5-Propyl-2-thiouracil
C7H10N2OS
Acta Crystallographica Section C (2014) 70, 2 241-249
a=8.6637(10)Å b=10.3098(13)Å c=10.7255(13)Å
α=76.253(10)° β=71.401(9)° γ=70.983(9)°